NOBELPARALLEL: payments to doctors
Payments that named NOBELPARALLEL as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.7M
- Providers
- 10,081
- Transactions
- 27,898
- Average per transaction
- $134
The per-transaction average — $134 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,081 providers the average total is $370, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Nobel Biocare USA | $3,704,635 | 99.4% |
| Kerr Corporation | $10,729 | 0.3% |
| Ormco Corporation | $10,529 | 0.3% |
| Envista Holdings Corporation | $228 | 0.0% |